SureQuant Targeted Mass Spectrometry Standards and Assay Panel for Quantitative Analysis of Phosphorylated Proteins from Multiple Signaling Pathways
Posters | 2021 | Thermo Fisher ScientificInstrumentation
Accurate measurement of dynamic protein phosphorylation is essential for understanding signaling pathways that govern normal cellular processes and drive disease states such as cancer. Targeted mass spectrometry workflows with internal standards enhance confidence in quantitation and facilitate comparison across experiments and laboratories.
This work introduces and evaluates two Thermo Scientific SureQuant phosphopeptide standards— the Phosphopeptide Suitability Standard and the Multipathway Phosphopeptide Standard—within a streamlined assay panel. Key objectives include:
Cell lines (MCF7, HCT116, A431, LNCaP, HepG2) were stimulated with growth factors (IGF-1, EGF), then lysed and digested using the EasyPep workflow. Heavy-labeled Multipathway phosphopeptide standards were spiked in before or after enrichment. Phosphopeptide enrichment strategies included the new Hi-Select Fe-NTA magnetic agarose and SMOAC, with comparison to a competitor Fe-NTA protocol. Enriched samples underwent nanoLC separation on an Acclaim PepMap C18 column (50 cm, 2–35% acetonitrile, 120 min gradient) and analysis by:
The combination of SureQuant phosphopeptide standards, optimized enrichment protocols, and targeted acquisition delivers a robust platform for quantitative analysis of phosphorylation across multiple signaling pathways. This workflow enhances sensitivity, reproducibility, and applicability to both basic research and translational studies.
Consumables, LC/HRMS, LC/MS, LC/MS/MS, LC/Orbitrap
IndustriesProteomics
ManufacturerThermo Fisher Scientific
Summary
Importance of the Topic
Accurate measurement of dynamic protein phosphorylation is essential for understanding signaling pathways that govern normal cellular processes and drive disease states such as cancer. Targeted mass spectrometry workflows with internal standards enhance confidence in quantitation and facilitate comparison across experiments and laboratories.
Goals and Overview of the Study
This work introduces and evaluates two Thermo Scientific SureQuant phosphopeptide standards— the Phosphopeptide Suitability Standard and the Multipathway Phosphopeptide Standard—within a streamlined assay panel. Key objectives include:
- Assessing LC-MS/MS system performance using the Suitability Standard.
- Quantifying phosphorylation events across multiple signaling pathways with the Multipathway Standard.
- Comparing enrichment and acquisition methods to maximize sensitivity and reproducibility.
Methodology
Cell lines (MCF7, HCT116, A431, LNCaP, HepG2) were stimulated with growth factors (IGF-1, EGF), then lysed and digested using the EasyPep workflow. Heavy-labeled Multipathway phosphopeptide standards were spiked in before or after enrichment. Phosphopeptide enrichment strategies included the new Hi-Select Fe-NTA magnetic agarose and SMOAC, with comparison to a competitor Fe-NTA protocol. Enriched samples underwent nanoLC separation on an Acclaim PepMap C18 column (50 cm, 2–35% acetonitrile, 120 min gradient) and analysis by:
- Discovery DDA on a Q Exactive HF
- PRM acquisition constrained for sensitivity and cycle time
- SureQuant targeted acquisition using a two-step survey and trigger approach on an Orbitrap Exploris 480
Used Instrumentation
- Thermo Scientific EASY‐nLC 1200 and UltiMate 3000 RSLCnano systems
- Thermo Scientific Q Exactive HF Hybrid Quadrupole‐Orbitrap
- Thermo Scientific Orbitrap Exploris 480
- Acclaim PepMap RSLC C18 trap and EASY‐Spray C18 analytical columns
- Hi‐Select Fe‐NTA magnetic agarose and SMOAC reagents
- Thermo Scientific EasyPep digestion kits and Pierce desalting spin columns
- Software: Proteome Discoverer 2.2 (SEQUEST HT) and Skyline
Main Results and Discussion
- The Phosphopeptide Suitability Standard reliably monitors LC-MS/MS system readiness and performance metrics.
- Multipathway Standard spiking enabled detection and quantitation of 131 phosphosites across EGFR/HER, RAS-MAPK, PI3K/AKT/mTOR, AMPK, apoptosis, and stress pathways.
- Hi-Select Fe-NTA enrichment outperformed SMOAC and competitor methods in phosphopeptide yield and signal intensity.
- SureQuant targeted acquisition achieved up to 4× higher sensitivity compared to DDA and conventional PRM, ensuring robust detection of low-abundance phosphorylation events.
- Quantitative changes in phosphorylation were observed across multiple treated cell lines, highlighting pathway-specific regulation patterns.
Benefits and Practical Applications
- Turnkey workflow for system suitability testing and targeted phosphoproteomics.
- High accuracy and precision support mechanistic studies, biomarker validation, and drug response profiling.
- Standardized reagents and protocols improve reproducibility across laboratories and experiments.
Future Trends and Applications
- Expansion of targeted panels to cover additional signaling networks and post-translational modifications.
- Integration with multiplexed isobaric labeling or DIA strategies for broader coverage.
- Automation of sample preparation and data analysis workflows to enable high-throughput screening.
- Application in clinical and single-cell phosphoproteomics to support precision medicine.
Conclusion
The combination of SureQuant phosphopeptide standards, optimized enrichment protocols, and targeted acquisition delivers a robust platform for quantitative analysis of phosphorylation across multiple signaling pathways. This workflow enhances sensitivity, reproducibility, and applicability to both basic research and translational studies.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
SureQuant Targeted Mass Spectrometry Standards and Assay Panel for Quantitative Analysis of Phosphorylated Proteins from Multiple Signaling Pathways 
2021|Thermo Fisher Scientific|Posters
SureQuant Targeted Mass Spectrometry Standards and Assay Panel for Quantitative Analysis of Phosphorylated Proteins from Multiple Signaling Pathways Bhavin Patel1, Penny Jensen1, Amirmansoor Hakimi2, Sebastien Gallien3,4, Aaron Gajadhar2, Ana Martinez Del Val5, Jesper Olsen5, Andreas Huhmer2, Daniel Lopez-Ferrer2, Ryan Bomgarden1,…
Key words
phosphopeptide, phosphopeptidesignaling, signalingphosphorylated, phosphorylatedsurequant, surequantnta, ntapathways, pathwaysenrichment, enrichmentmultipathway, multipathwayprm, prmphosphosites, phosphositesmagnetic, magneticphosphopeptides, phosphopeptidesphosphorylation, phosphorylationskyline, skylinebead
Turnkey, Multi-pathway Signaling Analysis Using a Synthetic Phosphopeptide Panel, Standardized Sample Preparation Kits and SureQuant Internal Standard Targeted Quantitation
2020|Thermo Fisher Scientific|Posters
Turnkey, Multi-pathway Signaling Analysis Using a Synthetic Phosphopeptide Panel, Standardized Sample Preparation Kits and SureQuant Internal Standard Targeted Quantitation Aaron S. Gajadhar1; Bhavin Patel2; Penny Jensen2; Sebastien Gallien3,4; Romain Huguet1; Kay Opperman2; John C Rogers2; Andreas Huhmer1; Daniel Lopez-Ferrer1 1Thermo…
Key words
surequant, surequantsmoac, smoacphosphopeptide, phosphopeptidesignaling, signalingprm, prmphosphopeptides, phosphopeptidesendogenous, endogenouspathway, pathwayenrichment, enrichmenthiselecttm, hiselecttmmultipathway, multipathwaytargeted, targetedconstrain, constraindda, ddaode
Quantitative, comprehensive multi-pathway signaling analysis using an optimized phosphopeptide enrichment method combined with an internal standard triggered targeted MS assay
2019|Thermo Fisher Scientific|Posters
Quantitative, comprehensive multi-pathway signaling analysis using an optimized phosphopeptide enrichment method combined with an internal standard triggered targeted MS assay Bhavin Patel1; Penny Jensen1; Aaron S. Gajadhar2; Sebastien Gallien3; Jae Choi1; Romain Huguet2; Graeme McAlister2; Derek Bailey2; Shannon Eliuk2; Markus…
Key words
phosphopeptide, phosphopeptidesignaling, signalingsurequant, surequanthela, helaphosphopeptides, phosphopeptideshegf, hegfsmoac, smoacpathway, pathwayegf, egfenrichment, enrichmentheavy, heavysmaoc, smaocpeptides, peptideshiselecttm, hiselecttmenriched
Quantitative, comprehensive multi-pathway signaling analysis using an optimized phosphopeptide enrichment method combined with an internal standard triggered targeted MS assay
2019|Thermo Fisher Scientific|Posters
Quantitative, comprehensive multi-pathway signaling analysis using an optimized phosphopeptide enrichment method combined with an internal standard triggered targeted MS assay Bhavin Patel1; Penny Jensen1; Aaron S. Gajadhar2; Sebastien Gallien3; Jae Choi1; Romain Huguet2; Graeme McAlister2; Derek Bailey2; Shannon Eliuk2; Markus…
Key words
phosphopeptide, phosphopeptidesurequant, surequanthela, helasignaling, signalingphosphopeptides, phosphopeptideshegf, hegfsmoac, smoacegf, egfheavy, heavysmaoc, smaocenrichment, enrichmenthiselecttm, hiselecttmenriched, enrichedpeptides, peptidespathway